SYNTHETIC CHIMERIC POXVIRUSES

CHIMERIC POXVIRUSES

SYNTHETIC CHIMERIC POXVIRUSES

ONCOLYTIC VIRUS EXPRESSING A CAR T CELL TARGET AND USES THEREOF

NON-INVASIVE AGENT APPLICATOR

SYNTHETIC CHIMERIC POXVIRUSES

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING ANTICANCER VIRUS, IMMUNE CHECKPOINT INHIBITOR AND HYDROXYUREA AS ACTIVE INGREDIENTS

Non-invasive agent applicator

Poxvirus host range protein K3 as a positive selection marker for generation of recombinant poxviruses, a therapeutic target for poxvirus infection and a therapeutic agent for PKR related diseases

Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors

ONCOLYTIC VIRUS EXPRESSING A CAR T CELL TARGET AND USES THEREOF

Poxvirus-recombinants, compositions containing such recombinants, uses thereof, and methods of making and using the same

Anti-cancer oncolytic virus combination therapies and elite responder selection platforms

Method of treatment using oncolytic viruses

Synthetic chimeric poxviruses

Salmon gill poxvirus

Non-Invasive Agent Applicator

COMPOSITIONS AND METHODS FOR INDUCING AN ENHANCED IMMUNE RESPONSE USING POXVIRUS VECTORS

Fusion polypeptides and vaccines

MVA virus and uses thereof

Stabilizing Formulations for Recombinant Viruses

POXVIRUS-PLASMODIUM RECOMBINANTS, COMPOSITIONS CONTAINING SUCH RECOMBINANTS, USES THEREOF, AND METHODS OF MAKING AND USING SAME

STABILIZING FORMULATIONS FOR RECOMBINANT VIRUSES

Immunological compositions